Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01361620 · ClinicalTrials.gov registry record · NA
Genotypic and Phenotypic Correlates of Resistance to Aspirin
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT01361620: Completed NA study, sponsored by George Washington University.
NCT01361620 is a NA study that has completed, run by George Washington University. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01361620, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The study seeks to identify genomic markers associated with aspirin resistance.
Primary Outcome
Whole blood coagulation after stimulation with arachidonic acid, as measured in the VerifyNow Aspirin system (Accumetrics). Aspirin response units (ARU) are the residual coagulation present in patients taking aspirin. The higher the ARU, the greater residual coagulation (resistance) to the aspirin effect.
Interventions
- DRUG aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01361620 record still lists
NCT01361620 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which aspirin is the first listed.
NCT01361620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01361620 about?
NCT01361620 is a clinical study titled "Genotypic and Phenotypic Correlates of Resistance to Aspirin". The study seeks to identify genomic markers associated with aspirin resistance.
What is the current status of trial NCT01361620?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2007-12. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01361620?
The interventions under investigation include: aspirin (DRUG).
Who is sponsoring clinical trial NCT01361620?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01361620's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia